Chantix Side-Effects May Halt Rare Pfizer Success Story 19 comments
-
Font Size:
-
Print
- TweetThis
Having been touted as one of Pfizer’s (PFE) few pipeline success stories in recent years, sales expectations for smoking cessation drug Chantix look set to be reined in following a number of high profile side-effect warnings, the latest coming Wednesday in a report suggesting a link to heart problems, seizures and diabetes.

The US pharma giant will be cursing its luck considering Chantix has represented the group’s biggest product forecast upgrade by analysts over the last 12 months, with estimates for 2012 almost doubling to $2.28bn, due to rapid uptake since its launch in August 2006. This upgrade to consensus forecasts represents the tenth largest by sales in the industry over the last year, according to archive forecast data from EvaluatePharma.
Wednesday’s report by The Institute for Safe Medication Practices [ISMP], released after market, prompted the Federal Aviation Administration to ban its pilots and air-traffic controllers from using the drug, as a result of a possible link to behavioral problems and drowsiness.
Despite the fact that the report has not been subject to peer-review scrutiny and published in a medical journal, or that establishing a causal relationship between a drug and a side effect is extremely difficult, the furore has left its mark, with Pfizer’s shares at a 10-year low of $19.53.
Revised consensus
Pfizer updated its Chantix label in November, and then more prominently in January, to include warnings about serious psychiatric effects such as depression and suicidal behavior.
The FDA is already conducting a safety review of Chantix, issuing an advisory statement in February that a link between use of the drug and adverse psychiatric events seems “increasingly likely”. The regulator’s response so far to this latest report is that current staffing shortages at the FDA mean a wider safety review, to include these additional possible side-effects, is not possible in the near future.
All of which means that sales growth in the first quarter showed signs of slowing down, with sales actually lower than the previous fourth quarter of 2007. US sales in the first quarter were $193m, representing 70% of global sales.
click to enlarge image
MAT = moving annual total (sum of previous four quarters)
Revised consensus forecasts, due to be published in EvaluatePharma later this month, suggests the downward revision has already started, with a 10% reduction in 2008 worldwide sales to $1.26bn.
How much further these forecast reductions are likely to go remains to be seen, but some analysts have so far suggested downgrades by as much as 30%, in light of the ISMP report.
Crucial to Pfizer
The importance of Chantix to Pfizer cannot be underestimated given it is the group’s second biggest growth driver over the next five years behind Lyrica, a treatment for various neurological disorders including epilepsy and fibromyalgia.
The drug also represents the company’s fifth most valuable product, with a consensus NPV of $6.17bn, equating to around 5% of Pfizer’s latest share price. As such, any reductions to the potential sales of the drug will have a significant impact on future cash flows, all the more critical once Lipitor is exposed to generic competition in 2010.
Investors will therefore be hoping that the company can quickly counter-balance this latest negative news and reinforce the risk-benefit profile of using their drug to quit smoking. If the issue continues to snowball, the knock-on effect to sales in Europe and Japan, where it has just been launched, could hurt the company further.
Related Articles
|






















This article has 19 comments:
Maybe you should change doctors if your doctor prescribed a drug without having done a complete checkup on your husband. If your husband was in great health before, I see a big lawsuit in your favor.
On May 26 10:31 AM BlueOkie wrote:
> no guinea pig,
> Maybe you should change doctors if your doctor prescribed a drug
> without having done a complete checkup on your husband. If your
> husband was in great health before, I see a big lawsuit in your favor.
>
>
A blocked artery, malignant hypertension, do not occur suddenly, but have been developing for years. Lifestyle choices are #1 in causation!
On May 26 03:53 AM no guinea pig wrote:
> My husband took this drug for about 1 month and ended up in the hospital.
> He had extremely high blood pressure, couldn't remember the names
> of his mother, children, or siblings, and thought I was his nurse
> (we've been married 22 yrs.). Seems he had a mini-stroke. He had
> to have surgery a week later for a blocked artery. He'd never had
> any health problems before. So, your guess is as good as mine. Was
> it the Chantix? I'm suspicious. Maybe all new comers should have
> a complete heart check up before taking this drug. Then if problems
> suddenly occur, you'll have a better idea who and what is to blame.
I just read the above article on Chantix. This quote is interesting:
"..posted online by the non-profit Institute for Safe Medication Practices. Co-author Curt Furberg, a Wake Forest University medical epidemiologist, said he and his coauthors felt "this was too important" to submit first to a medical journal, which could take six months or more to publish."
Wake Forest University (WFU) is located in Winston-Salem, North Carolina, which also happens to be the home of the RJ Reynolds Tobacco Company. In fact, WFU sits on land donated to it by Mary Reynolds (then owner of RJ Reynolds) and Reynolds Trusts and the company have always been generous supporters WFU.
Why, of all universities, did WFU conduct this research? The conflict of interest on the part of WFU is palpable. Mr. Furberg thought this was of "too important" to submit to medical journals (who would examine sources) but perhaps the media would not be so picky. To important to who? In my opinion to RJ Reynolds Tobacco Co. and the tobacco interests who are trying very hard to trash Chantix.
It is amazing that people are trashing a drug which has been extremely effective at weaning smokers. By the way, have I mentioned that SMOKING WILL KILL YOU. Bad dreams, odd behavior, so what!
my 21 year old neice is in a psych ward right now because of chantix and who knows if she will ever come out of this state of mind.
"so what"?
On May 28 12:29 PM jwaydog wrote:
> Let's face it....smoking kills people. Therefore, if you are taking
> this drug you were already crazy for being a smoker.
> It is amazing that people are trashing a drug which has been extremely
> effective at weaning smokers. By the way, have I mentioned that SMOKING
> WILL KILL YOU. Bad dreams, odd behavior, so what!